Skip to main content
Premium Trial:

Request an Annual Quote

CMI Establishes Initiative to Advance Next-Generation Drug Discovery

NEW YORK, March 29 (GenomeWeb News) - The Cambridge-MIT Institute said last week that it is launching a new initiative to bring researchers from different disciplines together to help accelerate advances in drug discovery.


CMI said it is funding the Next-Generation Drug Discovery Community, which will unite CambridgeUniversityand MIT researchers from fields such as computer science and physics with partners from the information technology and biopharmaceutical industries.


According to CMI, the alliance will work on new methods of overcoming bottlenecks in the drug discovery and development process. The effort is designed to advance the development of techniques for the rapid and quantitative experimental measurement of the gene- and protein-level properties of cells and tissues simultaneously, as well as to offer computer-aided analysis of the meaning of these data.


The community's first projects will involve studying adult blood stem cells as experimental systems for testing the efficacy and toxicity of drugs, and establishing new computational methods to identify drug targets, said CMI.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.